Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Insulet (PODD) has a market cap of $18.01 billion USD. According to our data, Insulet is ranked No.1011 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $18.01 B |
-1.67%
|
| Dec 31, 2024 | $18.31 B |
20.32%
|
| Dec 29, 2023 | $15.22 B |
-26.30%
|
| Dec 30, 2022 | $20.65 B |
10.64%
|
| Dec 31, 2021 | $18.66 B |
4.08%
|
| Dec 31, 2020 | $17.93 B |
49.32%
|
| Dec 31, 2019 | $12.01 B |
115.83%
|
| Dec 31, 2018 | $5.56 B |
14.96%
|
| Dec 29, 2017 | $4.84 B |
83.12%
|
| Dec 30, 2016 | $2.64 B |
-0.34%
|
| Dec 31, 2015 | $2.65 B |
-17.91%
|
| Dec 31, 2014 | $3.23 B |
24.15%
|
| Dec 31, 2013 | $2.60 B |
74.84%
|
| Dec 31, 2012 | $1.49 B |
12.69%
|
| Dec 30, 2011 | $1.32 B |
21.48%
|
| Dec 31, 2010 | $1.09 B |
8.54%
|
| Dec 31, 2009 | $1.00 B |
84.97%
|
| Dec 31, 2008 | $0.54 B |
-67.12%
|
| Dec 31, 2007 | $1.65 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Medtronic
MDT
|
$105.64 B |
0.002 M
|
Ireland
|
 DexCom
DXCM
|
$27.15 B |
0.001 M
|
USA
|
 Tandem Diabetes Care
TNDM
|
$1.18 B |
-0.000 M
|
USA
|
 Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
USA
|
 Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
Denmark
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
USA
|
 Senseonics Holdings
SENS
|
$0.40 B |
0.000 M
|
USA
|
 Insulet
PODD
|
$18.01 B |
0.000 M
|
USA
|
| Market Cap | = | PODD Stock Price | * | PODD Shares Outstanding |
| = | $256.42 | * | 70.23 M | |
| = | $18.01 B |